vs
Side-by-side financial comparison of COLLEGIUM PHARMACEUTICAL, INC (COLL) and Vroom, Inc. (VRM). Click either name above to swap in a different company.
Vroom, Inc. is the larger business by last-quarter revenue ($235.9M vs $205.4M, roughly 1.1× COLLEGIUM PHARMACEUTICAL, INC). COLLEGIUM PHARMACEUTICAL, INC runs the higher net margin — 8.3% vs -59.8%, a 68.1% gap on every dollar of revenue. On growth, Vroom, Inc. posted the faster year-over-year revenue change (12.9% vs 12.9%). COLLEGIUM PHARMACEUTICAL, INC produced more free cash flow last quarter ($122.4M vs $-108.8M). Over the past eight quarters, COLLEGIUM PHARMACEUTICAL, INC's revenue compounded faster (19.1% CAGR vs -49.5%).
Collegium Pharmaceutical, Inc. is a specialty pharmaceutical firm focused on developing and commercializing innovative, abuse-deterrent pain management therapies. Operating primarily in the U.S. market, it offers extended-release analgesics for chronic pain patients, serving providers across primary and specialty care segments.
Vroom, Inc. is a parent company of United Auto Credit Corporation (UACC) and CarStory. Previously, Vroom was a used car retailer and e-commerce company that let consumers buy, sell, and finance cars online. Vroom ceased e-commerce automotive sales operations on January 22, 2024.
COLL vs VRM — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2023
| Metric | | |
|---|---|---|
| Revenue | $205.4M | $235.9M |
| Net Profit | $17.0M | $-141.1M |
| Gross Margin | 62.5% | 12.3% |
| Operating Margin | 29.6% | -11.5% |
| Net Margin | 8.3% | -59.8% |
| Revenue YoY | 12.9% | 12.9% |
| Net Profit YoY | 35.3% | -669.8% |
| EPS (diluted) | $0.48 | $-80.66 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $205.4M | — | ||
| Q3 25 | $209.4M | — | ||
| Q2 25 | $188.0M | — | ||
| Q1 25 | $177.8M | — | ||
| Q4 24 | $181.9M | — | ||
| Q3 24 | $159.3M | — | ||
| Q2 24 | $145.3M | — | ||
| Q1 24 | $144.9M | — |
| Q4 25 | $17.0M | — | ||
| Q3 25 | $31.5M | — | ||
| Q2 25 | $12.0M | — | ||
| Q1 25 | $2.4M | — | ||
| Q4 24 | $12.5M | — | ||
| Q3 24 | $9.3M | — | ||
| Q2 24 | $19.6M | — | ||
| Q1 24 | $27.7M | — |
| Q4 25 | 62.5% | — | ||
| Q3 25 | 61.7% | — | ||
| Q2 25 | 57.7% | — | ||
| Q1 25 | 54.8% | — | ||
| Q4 24 | 54.0% | — | ||
| Q3 24 | 60.8% | — | ||
| Q2 24 | 62.5% | — | ||
| Q1 24 | 63.1% | — |
| Q4 25 | 29.6% | — | ||
| Q3 25 | 29.7% | — | ||
| Q2 25 | 18.7% | — | ||
| Q1 25 | 12.2% | — | ||
| Q4 24 | 20.9% | — | ||
| Q3 24 | 21.9% | — | ||
| Q2 24 | 32.7% | — | ||
| Q1 24 | 34.1% | — |
| Q4 25 | 8.3% | — | ||
| Q3 25 | 15.0% | — | ||
| Q2 25 | 6.4% | — | ||
| Q1 25 | 1.4% | — | ||
| Q4 24 | 6.9% | — | ||
| Q3 24 | 5.9% | — | ||
| Q2 24 | 13.5% | — | ||
| Q1 24 | 19.1% | — |
| Q4 25 | $0.48 | — | ||
| Q3 25 | $0.84 | — | ||
| Q2 25 | $0.34 | — | ||
| Q1 25 | $0.07 | — | ||
| Q4 24 | $0.36 | — | ||
| Q3 24 | $0.27 | — | ||
| Q2 24 | $0.52 | — | ||
| Q1 24 | $0.71 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $386.7M | $135.6M |
| Total DebtLower is stronger | — | $454.2M |
| Stockholders' EquityBook value | $301.7M | $127.7M |
| Total Assets | $1.7B | $1.5B |
| Debt / EquityLower = less leverage | — | 3.56× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $386.7M | — | ||
| Q3 25 | $285.9M | — | ||
| Q2 25 | $222.2M | — | ||
| Q1 25 | $197.8M | — | ||
| Q4 24 | $162.8M | — | ||
| Q3 24 | $120.0M | — | ||
| Q2 24 | $271.6M | — | ||
| Q1 24 | $318.0M | — |
| Q4 25 | $301.7M | — | ||
| Q3 25 | $274.8M | — | ||
| Q2 25 | $232.2M | — | ||
| Q1 25 | $234.4M | — | ||
| Q4 24 | $228.8M | — | ||
| Q3 24 | $234.3M | — | ||
| Q2 24 | $216.6M | — | ||
| Q1 24 | $222.2M | — |
| Q4 25 | $1.7B | — | ||
| Q3 25 | $1.6B | — | ||
| Q2 25 | $1.6B | — | ||
| Q1 25 | $1.6B | — | ||
| Q4 24 | $1.7B | — | ||
| Q3 24 | $1.6B | — | ||
| Q2 24 | $1.1B | — | ||
| Q1 24 | $1.1B | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $123.0M | $-108.1M |
| Free Cash FlowOCF − Capex | $122.4M | $-108.8M |
| FCF MarginFCF / Revenue | 59.6% | -46.1% |
| Capex IntensityCapex / Revenue | 0.3% | 0.3% |
| Cash ConversionOCF / Net Profit | 7.25× | — |
| TTM Free Cash FlowTrailing 4 quarters | $327.6M | $-536.3M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $123.0M | — | ||
| Q3 25 | $78.4M | — | ||
| Q2 25 | $72.4M | — | ||
| Q1 25 | $55.4M | — | ||
| Q4 24 | $84.6M | — | ||
| Q3 24 | $-9.0M | — | ||
| Q2 24 | $67.4M | — | ||
| Q1 24 | $61.9M | — |
| Q4 25 | $122.4M | — | ||
| Q3 25 | $78.3M | — | ||
| Q2 25 | $72.4M | — | ||
| Q1 25 | $54.6M | — | ||
| Q4 24 | $84.1M | — | ||
| Q3 24 | $-9.2M | — | ||
| Q2 24 | $67.1M | — | ||
| Q1 24 | $61.4M | — |
| Q4 25 | 59.6% | — | ||
| Q3 25 | 37.4% | — | ||
| Q2 25 | 38.5% | — | ||
| Q1 25 | 30.7% | — | ||
| Q4 24 | 46.2% | — | ||
| Q3 24 | -5.8% | — | ||
| Q2 24 | 46.2% | — | ||
| Q1 24 | 42.3% | — |
| Q4 25 | 0.3% | — | ||
| Q3 25 | 0.1% | — | ||
| Q2 25 | 0.0% | — | ||
| Q1 25 | 0.4% | — | ||
| Q4 24 | 0.3% | — | ||
| Q3 24 | 0.2% | — | ||
| Q2 24 | 0.2% | — | ||
| Q1 24 | 0.4% | — |
| Q4 25 | 7.25× | — | ||
| Q3 25 | 2.49× | — | ||
| Q2 25 | 6.05× | — | ||
| Q1 25 | 22.92× | — | ||
| Q4 24 | 6.75× | — | ||
| Q3 24 | -0.96× | — | ||
| Q2 24 | 3.44× | — | ||
| Q1 24 | 2.23× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
